3-times-a-week COPAXONE® (glatiramer acetate injection) 40 mg NOW AVAILABLE     Dear [Field: First Name],   You chose COPAXONE® because you and your doctor decided it worked best for you and your lifestyle. Though we know that it may still feel like a new part of your routine, the treatment options continue to build. Now you can have the established track record of the COPAXONE® brand, plus the freedom to dose 3 times a week, at least 48 hours apart. • Proven effectiveness1 • Demonstrated safety and tolerability profile1 • The #1 prescribed brand for relapsing MS in the US2* • The Shared Solutions® network of personalized support   Take control of your relapsing MS by choosing a therapy with proven results.     Make a commitment—and stay the course with a therapy you trust.     Arrange your treatment around your life—not your life around your treatment.                 For support or additional information, please call Shared Solutions® at 1-800-887-8100, or visit www.copaxone.com. Talk to your doctor about getting started with 3-times-a-week COPAXONE® 40 mg.             COPAXONE® (glatiramer acetate injection) is indicated for the treatment of patients with relapsing forms of multiple sclerosis. Important Safety Information Do not take COPAXONE® if you are allergic to glatiramer acetate or mannitol. Some patients report a short-term reaction right after injecting COPAXONE®. This reaction can involve flushing (feeling of warmth and/or redness), chest tightness or pain with heart palpitations, anxiety, and trouble breathing. These symptoms generally appear within minutes of an injection, last about 15 minutes, and do not require specific treatment. During the postmarketing period, there have been reports of patients with similar symptoms who received emergency medical care. If symptoms become severe, call the emergency phone number in your area. Call your doctor right away if you develop hives, skin rash with irritation, dizziness, sweating, chest pain, trouble breathing, or severe pain at the injection site. If any of the above occurs, do not give yourself any more injections until your doctor tells you to begin again. Chest pain may occur either as part of the immediate postinjection reaction or on its own. This pain should only last a few minutes. You may experience more than one such episode, usually beginning at least one month after starting treatment. Tell your doctor if you experience chest pain that lasts for a long time or feels very intense. A permanent indentation under the skin (lipoatrophy or, rarely, necrosis) at the injection site may occur, due to local destruction of fat tissue. Be sure to follow proper injection technique and inform your doctor of any skin changes. The most common side effects in studies of COPAXONE® are redness, pain, swelling, itching, or a lump at the site of injection, flushing, rash, shortness of breath, and chest pain. These are not all of the possible side effects of COPAXONE®. For a complete list, ask your doctor or pharmacist. Tell your doctor about any side effects you have while taking COPAXONE®. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. Please see full Prescribing Information. Your Shared Solutions® Team *Based on total number of prescriptions for relapsing forms of MS (IMS National Rx Audit, September 2013). References: 1. COPAXONE® (glatiramer acetate injection) prescribing information. Teva Neuroscience, Inc. 2. IMS Health National Prescription Audit, September 2013. Data proprietary to IMS Health. Privacy Policy  |  [Response: One Click Unsub]  |  Terms of Use COPAXONE® is a registered trademark of Teva Pharmaceutical Industries Ltd. Shared Solutions® is a registered service mark of Teva Neuroscience, Inc. © 2014 Teva Neuroscience, Inc. COP-41550 Teva Neuroscience, Inc., COPAXONE® Marketing, 11100 Nall Avenue, Overland Park, KS 66211